Paris, June 26, 2013 - Cellectis (Alternext: ALCLS), the genome engineering specialist, announced today that it has successfully used engineered nucleases to genetically reprogram...
- Europe and International: + 33 (0)1 81 69 16 01
- USA and Canada: + 1 (617) 583-3199